Breast & Cervical Cancer Screening

Federal/State Program Aims to Lower Mortality Among Poor Women

Nitsa Allen-Barash
Veronica Foster
William H. Mitchell
Robert Fletcher

 Death from cervical cancer should be completely preventable. Both incidence and mortality rates from cervical cancer are highest among women of minority groups. While white women experience the highest incidence of breast cancer, African-American women have the highest mortality rate because fewer are diagnosed at an early stage. Screening for breast and cervical cancer lowers mortality, but poor women are less likely to be screened than those at higher income levels (Figure 1).
Table on clinical breast exams & mammograms reported In Washington in 1994, 29% of poor women aged 51 and older had never had a mammogram, and nearly 6% had never had a Pap smear. By contrast, only 9% of more affluent women in this age group had never had a mammogram and approximately 2% had never had a Pap smear. Among women in this age group who had been screened previously, only about 22% of poor women had received a mammogram in the past year, compared to about 78% of more affluent women. About 52% of poor women reported having a Pap smear in the previous two years, compared to 80% of more affluent women.

The federal Breast and Cervical Cancer Mortality Prevention Act of 1990 addresses this problem by providing federal funds for cancer screening and related services for poor women who are uninsured or whose medical insurance does not provide full screening coverage. This act and subsequent congressional appropriations provided both the impetus and resources for the establishment of the national Breast and Cervical Cancer Early Detection Program by the Centers for Disease Control and Prevention. Its aim is to minimize mortality among uninsured and underinsured women who are 40 years and older, and particularly among those 50 and older. The program's provision of free breast and cervical

 cancer screening and confirmatory diagnostic tests should contribute to the removal of financial barriers to screening and should result in higher screening rates for the target population. Washington and five other states began receiving funds for screening in 1993. Additional appropriations have provided funding to all states, the District of Columbia, and to several territories.

Washington's Program

In 1994, mortality from breast cancer in Washington State was highest among African-American women at 35 deaths per 100,000 -- 50% higher than the general rate. The death rate from cervical cancer was highest among Native Americans, and at 5.5 deaths per 100,000 was more than twice the general rate. In September 1993, Washington initiated a five-year Breast and Cervical Health Program (BCHP). Sixty percent of the $12 million granted by the CDC are designated for the provision of screening services; 40% are dedicated to the development and implementation of program activities that support the goal of early detection. Clinics are paid to coordinate and provide services. Local health jurisdictions and community agencies were contracted to coordinate services. The Washington State Department of Health promotes screening of the target population.

Program Services

The program provides free regular screening mammograms, cervical cytology, and confirmatory diagnostic tests for women of low income (at or below 200% of the federal poverty level) who are un- or underinsured. While women as young as 40 years of age are eligible for services, the focus has been on those aged 50 and older. This policy is consistent with CDCs goal of dedicating 90% of the funds to screen this older group, for whom mammograms are most effective in detecting early cancers and reducing mortality.

The program has a special mandate to work with the federally funded community and migrant health centers. While they may not be able to provide all needed medical services, these clinics take responsibility for coordinating them for their patients. Twenty-four of the 26 centers operating in Washington State, several of which especially serve minorities, participate in the BCHR The program provides screening resources and training to 10 Native American tribes and to 140 private clinics and providers who administer care to poor women in counties lacking public care clinics. To date, 76 mammography facilities are participating in the program.

Partnerships with the YWCA, American Cancer Society, Cancer Information Service, Susan G. Komen Foundation, local health departments, community care clinics, lesbian community groups, and many other groups have promoted screening services. Other program components include public education and outreach, professional education, quality assurance, surveillance, and evaluation.

Outreach: Data from previous studies and from similar programs and the results of ethnic-specific focus groups conducted with African-American, Native American, Hispanic, European-American, and Southeast Asian women contributed to the development of strategies for contacting women and for addressing potential barriers to initial screening. Outreach channels include social meetings, worksites, health fairs, beauty salons, newspaper, radio, and local television ads. Community women were hired by local health departments and community organizations to spread the word about the availability of the program's services to increase initial and repeat use by the target population.
Ad - Women Health Exam-Native Americans
Ad - Women's Health Exam-VietnameseFigure 2: Examples of posters used to reach women in specific ethnic groups. The top poster is aimed at Native Americans, the lower one at Vietnamese
 
 
Factors identified as barriers to free screening include lack of transportation, fear of cancer, distrust of doctors (particularly of male doctors), and spousal objection. Strategies include the provision of transportation fares and the inclusion of mobile mammography units in remote rural areas, and recruitment of eligible and previously screened women to explain the value of early diagnosis and to bring women to clinics for exams. Educational sessions for objecting spouses are conducted in some counties. While the program has developed and disseminated some ethnic-specific posters and materials (Figure 2), most of the activities are county-specific and are initiated and implemented by local agencies. The Cancer Information Service, a regional office of the National Cancer Institute, has a contract with BCHP to develop outreach activities specific to four of the participating tribes, and Group Health Cooperative is developing strategies relevant to uninsured women served by HMOs.

Professional Education: Staff at most of the federally funded community and migrant health centers in Washington were trained in the development and use of a reminder system to maximize repeated, regular screening. Staff of 11 randomly selected clinics received enhanced training to identify and address women's barriers to rescreening and received information on the risk factors for breast and cervix cancer, on screening guidelines, and on the value of regular screening.

Quality Assurance: Quality assurance focuses on the clinics, cytology labs, and mammography facilities, and includes clinic and facility audits and accuracy evaluation of cytologic interpretations. To date, agreement has been close to 100%. 

The program monitors standardized reporting procedures to ensure timely evaluation of abnormal results and the sensitivity and specificity rates of program mammograms; and cervical cytology. Factors affecting mammography sensitivity and specificity will be examined.

Program Surveillance: All medical services funded by the program are documented by all participating clinics, providers, facilities, and the lab. BCHP staff monitor program activities and provide periodic reports to clinics, facilities, and the CDC, which monitors the national program.

Program Evaluation: Mammography screening of large population groups is expected to save lives but not money Program evaluation focuses on the effect of outreach activities on initial program use, the effect of an enhanced clinic-based training on rescreening, the identification of barriers to rescreening, and the effect of the program on stage of cancer diagnosis. Surveys are used to evaluate outreach activities, the effect of clinic training, and other outcomes. Cancer registry data will be used to assess the program's effect on stage of diagnosis.
Table - Racial & ethnic distribution

Program Results

From May 1994 through fall 1996, approx imately 10,000 women have received BCHP services - about one-sixth of the estimated eligible target population. Forty-seven percent of the program women are nonwhite 46 (Table 1) and 47% are 50 years and older. The rates of prior cancer screening reported by BCHP patients were less than half those reported by more affluent Washingtonians of the same age range who participated in the 1994 Behavioral Risk Factor Survey.

As of October 1996, BCHP paid for 9,644 clinical breast exams, 7,854 mammograms, and 9,109 cervical cytologies. Among 9,278 women enrolled, 91% were referred for a mammograrn at the first visit and 93% of these complied. Eight percent of all first BCHP mammograms; were abnormal and 54 8.6% of these were diagnosed as breast cancer (12 in-situ, 31 invasive, and 11 pending diagnosis). Twenty-four cervical cancers (14 in-situ, 7 invasive, and 3 pending) were identified through the program. Among BCHP participants 50 years or older whose first BCHP mammogram was normal, 40% came to the clinic for a rescreening exam within 18 months of their initial mammogram.

Future Directions

The program expects to screen 15,000 women at least once by the end of the 1997 fiscal year and another 5,000 by September 1998. Current screening data suggest the need to identify and remove remaining barriers to program use, and to increase repeated, regular screening to reduce mortality among the target population. Training of outreach workers may emphasize skills needed to address specific barriers to increase the likelihood of contacting and affecting women who are harder to reach and possibly less motivated than those screened to date. Internal activities include improving clinic reminder systems and expanding patient education to help increase rescreening by 10-15%. Such expansion of the BCHP requires further development of local systems, including the involvement of additional private providers in the care of uninsured women, and the identification of local funding sources for screening and for treatment. These challenges are the focus of current program activities and those planned for the near future.

Recommended Reading

 Brooks SE: Cervical cancer screening and the older woman: Obstacles and opportunities. Cancer Prac 1996; 4(3):125-129.

 Burns RB, Freund KM, Ash A, et al: Who gets repeat screening mammography: The role of the physician. J Gen Intern Med 1995; 10:520-522.

 Eastman P: Task force issues new screening guide lines. J Natl Cancer Inst 1996, 88(2):74-78.

 Harper M: Mammography utilization in the poor and medically underserved. Cancer 1993; 72(4 Suppl): 1478-82.

 Kerlikowske K, Grady D, Rubin SM et al: Efficacy of screening mammography: A meta-analysis. JAMA 1995; 273:149-154.

 Lemkau J, Grady K, Carlson S: Maximizing the referral of older women for screening mammography. Arch Fam Med 1996; 5:174-178.

SEER Cancer Statistics Review, 1973-1992. NIH Publication No. 96-2789. Bethesda, MD: National Institutes of Health, National Cancer Institute, 1995.

Authors

Nitsa Allen-Barash, Ph.D., is the director of Breast and Cervical Health Program Evaluation, Washington State Department of Health, and affiliate assistant professor of epidemiology at the UW School of Public Health and Community Medicine.

 Veronica Foster, M.B.A., B.S.N., is the manager of the Breast and Cervical Health Program, Washington State Department of Health.

 William H. Mitchell, B.A., was the public health advisor assigned by the Centers for Disease Control and Prevention to the Breast and Cervical Health Program.

 Robert Fletcher, M.S., is the data manager for the Breast and Cervical Health Program.

Funded by a grant from the National Breast and Cervical Cancer Early Detection Program, Centers for Disease Control and Prevention.
 


Return to the Table of Contents
Return to Northwest Public Health


Created: 5/7/98 Updated: 7/14/99